Össur hf. provided earnings guidance for the year 2022. The financial guidance for the full year 2022 is 4% to 6% organic sales growth.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
28.7 DKK | -2.38% | -1.37% | +4.55% |
04-23 | Transcript : Embla Medical hf., Q1 2024 Earnings Call, Apr 23, 2024 | |
04-23 | Embla Medical hf. Provides Earnings Guidance for the Year 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.55% | 1.78B | |
-10.44% | 21.29B | |
+6.12% | 19.09B | |
+6.74% | 13.98B | |
+13.18% | 10.62B | |
-10.48% | 2.24B | |
+19.30% | 639M | |
0.00% | 372M | |
+93.03% | 223M | |
+20.48% | 94.82M |
- Stock Market
- Equities
- EMBLA Stock
- News Embla Medical hf.
- Össur hf. Provides Earnings Guidance for the Year 2022